4//SEC Filing
CASTLEMAN PETER M 4
Accession 0001239594-26-000003
CIK 0002019410other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 6:37 PM ET
Size
8.5 KB
Accession
0001239594-26-000003
Insider Transaction Report
Form 4
CASTLEMAN PETER M
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-09$18.60/sh+2,500$46,500→ 18,629 total - Exercise/Conversion
Stock Option
[F2]2026-01-09−2,500→ 0 totalExercise: $18.60Exp: 2035-02-27→ Common Stock (2,500 underlying)
Holdings
- 100,000(indirect: By Trust)
Common Stock
- 10,270,906(indirect: By LLC)
Common Stock
[F1]
Footnotes (2)
- [F1]CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F2]The stock option is fully vested and exercisable. These securities were previously reported on the Reporting Person's Form 3.
Signature
/s/ J. Russel Denton, Attorney-in-Fact|2026-01-13
Documents
Issuer
Caris Life Sciences, Inc.
CIK 0002019410
Entity typeother
Related Parties
1- filerCIK 0001239594
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 6:37 PM ET
- Size
- 8.5 KB